MTF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.36260003280597E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.59359994486874E-10 |
Normal-vs-Stage2 |
5.572900E-04 |
Normal-vs-Stage3 |
4.764400E-03 |
Normal-vs-Stage4 |
4.21290000000019E-05 |
Stage1-vs-Stage2 |
8.066800E-01 |
Stage1-vs-Stage3 |
8.082200E-01 |
Stage1-vs-Stage4 |
7.406000E-01 |
Stage2-vs-Stage3 |
9.741400E-01 |
Stage2-vs-Stage4 |
6.278400E-01 |
Stage3-vs-Stage4 |
7.099200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.46309994622607E-09 |
Normal-vs-AfricanAmerican |
9.94619997474189E-09 |
Normal-vs-Asian |
7.85650000000304E-05 |
Caucasian-vs-AfricanAmerican |
4.968400E-01 |
Caucasian-vs-Asian |
5.096600E-01 |
AfricanAmerican-vs-Asian |
5.805600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.13280496094603E-11 |
Normal-vs-Female |
4.257700E-02 |
Male-vs-Female |
1.044660E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.90829999977294E-07 |
Normal-vs-Extreme_Weight |
1.98200345025157E-11 |
Normal-vs-Obese |
8.32460000000923E-05 |
Normal-vs-Extreme_Obese |
2.07449999999332E-05 |
Normal_Weight-vs-Extreme_Weight |
4.755400E-01 |
Normal_Weight-vs-Obese |
3.206400E-01 |
Normal_Weight-vs-Extreme_Obese |
8.002600E-01 |
Extreme_Weight-vs-Obese |
6.054300E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.830200E-01 |
Obese-vs-Extreme_Obese |
4.303400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.228200E-01 |
Normal-vs-Age(41-60Yrs) |
2.56199999992823E-07 |
Normal-vs-Age(61-80Yrs) |
6.03920247144174E-11 |
Normal-vs-Age(81-100Yrs) |
1.38510000136094E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.330400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.858000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.509700E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.797500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.128310E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.994990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.49409945421542E-10 |
Normal-VS-Type2 PRCC |
3.64910324179846E-11 |
Normal-VS-KIRP CIMP |
8.919000E-01 |
Normal-VS-Unclassified PRCC |
3.823000E-03 |
Type1 PRCC-VS-Type2 PRCC |
2.100800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.792220E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.218600E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.264020E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.272000E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.301400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.75663994040588E-13 |
Normal-vs-N1 |
1.760640E-01 |
Normal-vs-N2 |
3.531200E-01 |
N0-vs-N1 |
8.154400E-02 |
N0-vs-N2 |
5.007800E-01 |
N1-vs-N2 |
8.438200E-01 |
|
|